Completed PHASE1 INTERVENTIONAL NCT00218530

Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1

Naltrexone and Lofexidine in Detoxified Heroin Addicts

Sponsor: National Institute on Drug Abuse (NIDA)

Interventions Lofexidine

Updated 5 times since 2017 Last updated: Jan 11, 2017 Started: Mar 31, 2003 Completion: Sep 30, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Heroin Dependence, this trial is completed. The trial is conducted by National Institute on Drug Abuse (NIDA) and has accumulated 5 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Mar 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)

Data source: National Institute on Drug Abuse (NIDA)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New Haven, United States